Use of Topical Finasteride Vs Systemic Finasteride in Male Pattern Baldness
Abstract:
In this study we have analyzed the use of finasteride which is a type P-selective 5a-reductase inhibitor. By decreasing dihydroxytestestrone (DHT) level, it is found to be effective in the treatment of male androgenic alopecia. In this study, we compared the effect of topical vs. systemic finasteride in the treatment of androgenic alopecia. Our study is a randomized clinical trial study having 30 male patients. They have come for alopecia treatment at Nesam hospital, Coimbatore, India. We have selected male patients with androgenic alopecia and divided them into two groups (A, B), randomly having 15 patients in each group. For group A, Topical finasteride (0.1%) with minoxidil (5%) solution was given. Group B patients received topical minoxidil with oral finasteride (1mg) tablets. All patients were regularly followed up till the end of 6 months. A Patient had a first review in the first week followed by monthly follow up. Following parameters were taken into account: size of bald area, total hair count, and terminal hair. Data was analyzed by Chi-square statistical test. Each month the terminal hair, size of bald area and hair count between the two groups were compared. In the initial few months group, A showed good improvement. But Serial measurements indicated that a significant increase in hair counts and terminal hair counts is seen in both groups. This study showed that on long term follow-up of more than 3 months, both topical and systemic finasteride groups had similar results.References:
[1] Lolli F, Pallotti F, Rossi A, Fortuna MC,
et al -2017 Androgenetic alopecia: a review. Endocrine. 2017;57(1):9–17.
[PubMed] [Google Scholar].
[2] Inui S, Itami S-2012. Androgen actions on
the human hair follicle: perspectives. ExpDermatol. doi:10.1111/exd.12024 [PubMed].
[3] El-Domyati M, Attia S, Saleh F, et al -
2009 Androgenetic alopecia in males: a histopathological and ultrastructural
study. J CosmetDermatol. 2009; 8(2)83–91.
[4] Noubarani M, Rostamkhani H, Erfan M,
Kamalinejad M, Eskandari MR, Babaeian M, Salamzadeh J. – 2014, Effect of
adiantum capillus veneris linn on an animal model of testosterone-induced hair
loss. Iran J Pharm Red. Winter; 13(Suppl): 113–118.
[5] Trueb RM.- 2002 Molecular mechanisms of androgenetic
alopecia. Ther Umsch ;59(5) 211–6.
[6] Finn DA, Beadles-Bohling AS, Beckley EH,
et al – 2006.A new look at the 5alpha-reductase inhibitor finasteride. Cns Drug
Rev; 12:53–76.
[7] Mazzarella GF, Loconsole GF, Cammisa GA,
Mastrolonardo GM & Vena (1997) Topical finasteride in the treatment of
androgenic alopecia. Preliminary evaluations after a 16-month therapy course,
Journal of Dermatological Treatment, 8:3, 189-192, DOI:
10.3109/09546639709160517.
[8] Caserini M, Radicioni M, Leuratti C, et al
– 2016, Effects of a novel finasteride 0.25% topical solution on scalp and
serum dihydrotestosterone in healthy men with androgenetic alopecia. Int J
ClinPharmacolTher; 54(1):19–27.
[9]
Robinson J Published December 18, 2016. Accessed July
04, 2017. Hair transplant: what to
expect–/skin-problems-and-treatments/hair-loss/men-hair-loss17/hair
transplant/WebMD https://www.webmd.com.
[10]
Dunlop F. 2005- Androgenetic alopecia in men
and women: An overview of cause and treatment. Available from: http://www.folicle.comsection
22.html.
[11]
Rafi AW, Katz RM –
2011, Pilot study of 15 patients receiving a new treatment regimen for
androgenic alopecia: the effects of atopy on AGA. ISRN Dermatol. 2011; 241953.
[12]
Hajheydari
Z, Akbari J, Saeedi M, Shokoohi L. Comparing the therapeutic effects of
finasteride gel and tablet in treatment of the androgenetic alopecia. Indian J
Dermatol Venereol Leprol. 2009 Jan-Feb;75(1):47-51. doi: 10.4103/0378-6323.45220.
PMID: 19172031.
[13]
Caserini M,
Radicioni M, Leuratti C, et al – 2014, A novel finasteride 0.25% topical
solution for androgenetic alopecia: pharmacokinetics and effects on plasma
androgen levels in healthy male volunteers. Int J Clin Pharmacol Ther.;52(10):842–9.
[14]
Lee
SW, Juhasz M, Mobasher P, Ekelem C, Mesinkovska NA. A Systematic Review of
Topical Finasteride in the Treatment of Androgenetic Alopecia in Men and
Women. J Drugs Dermatol. 2018;17(4):457-463.
[15]
Mazzarella GF,
Loconsole GF, Cammisa GA, Mastrolonardo GM & Vena - Received 23 Aug 1996, accepted 18 Mar
1997, Published online: 12 Jul 2009 - Topical finasteride in the treatment of
androgenic alopecia. Preliminary evaluations after a 16-month therapy course
Pages 189-192.
[16]
Price VH, Menefee
E, Sanchez M, Ruane P, Kaufman KD- 2002 Changes in hair weight and hair count
in men with androgenetic alopecia after treatment with finasteride, 1 mg, and
daily. J Am Acad Dermatol; 46:517-23.
[17]
Chandrashekar B S,
Nandhini T, Vasanth V, Sriram R, Navale S. Topical minoxidil fortified with
finasteride: An account of maintenance of hair density after replacing oral
finasteride. Indian Dermatol Online J 2015; 6:17-20.
